Yabao Pharmaceutical Group Co. Ltd. | Ownership
Companies that own Yabao Pharmaceutical Group Co. Ltd.
Minsheng Securities Co., Ltd. (Investment Management)
18,419,633
2.66%
-2,024,086
15.33%
07/18/2018
HSBC Jintrust Management Co., Ltd.
13,543,891
1.96%
13,543,891
0.7%
12/31/2017
China Investment Corp. (Investment Management)
12,842,300
1.86%
0
0.04%
07/18/2018
China Southern Asset Management Co., Ltd.
6,409,824
0.93%
4,698,860
0.06%
12/31/2017
AXA-SPDB Investment Managers Co., Ltd.
5,775,302
0.84%
-250,000
0.71%
09/30/2017
UBS SDIC Fund Management Co., Ltd.
4,445,782
0.64%
4,445,782
0.36%
09/30/2017
Manulife TEDA Fund Management Co., Ltd.
2,524,700
0.37%
2,524,700
0.08%
12/31/2017
China Asset Management Co., Ltd.
2,381,600
0.34%
0
0.01%
12/31/2017
The Vanguard Group, Inc.
893,483
0.13%
0
0%
07/31/2018
Truvalue Asset Management Co. Ltd.
650,300
0.09%
650,300
0.05%
12/31/2017
| Address |
11/F, Building 2, Yard 11
Beijing Beijing 100176
China
|
|
Employees
|
- |
| Website |
http://www.yabao.com.cn |
| Updated |
07/08/2019 |
| Yabao Pharmaceutical Group Co., Ltd. engages in the development, production, and sale of pharmaceutical products. It focuses on medicine and health business. The company's products include Chinese and western medicine preparations, raw materials, and pharmaceutical packaging materials, mainly for the elderly chronic drug and women and children medication; cardiovascular and cerebrovascular drugs, and health products. |
